Usefulness of Radiofrequency Ablation with the PVT-350BTP Probe for the treatment of Hepatocellular Carcinoma

Naoki Hotta, Kazuo Masuko

.

DOI: 10.4236/ojmi.2011.11002                

Abstract

Radiofrequency ablation (RFA) has been clinically employed in Japan, and its usefulness in the treatment of hepatocellular carcinoma (HCC) has been reported by many researchers. In the present study, the convex puncture probe PVT-350BTP, rather than a conventional convex probe, was used for RFA for the treatment of HCC and its usefulness was assessed. At the same time, evaluation of the therapeutic effect using ultrasound contrast agent was investigated. The subjects were 20 patients (16 men and 4 women) with 20 HCC nodules as confirmed by contrast CT or abdominal angiography. No nodules were ≤1.0 cm in diameter, 12 were 1.1 cm - 2.0 cm, and 8 were 2.1 cm - 3.0 cm. An Aplio diagnostic ultrasound system (Toshiba Medical Systems, Tokyo, Japan) and the PVT-350BTP probe (Toshiba) were employed for RFA. The PVT-350BTP supports puncture angles of 55, 70, 85, and 100 degrees. By mounting various types of puncture adapters on the probe, 13 G to 22 G puncture needles can be used. The needle can easily be attached and detached by operating a lever. Contrast echo studies with Levovist were performed before and after RFA, and the results were evaluated using the Advanced Dynamic Flow (ADF) imaging technique. Puncture was performed successfully using this probe for 20 cases with 20 nodules. It was confirmed that RFA with the PVT-350BTP permits percutaneous treatment to be performed more reliably than with a conventional probe.

Keywords

Ultrasound, RFA, HCC，PVT-350BTP

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	G. Francica and G. Marone, “Ultrasound-Guided Percutaneous Treatment of Hepatocellular Carcinoma by Radiofrequency Hyperthermia with a “Cooled-Tip Needle”: A Preliminary Clinical Experience,” European Journal of Ultrasound, Vol. 9, No. 2, 1999, pp. 145-153. doi:10.1016/S0929-8266(99)00022-1
[2]	T. Livraghi, N. Goldberg, S. Lazzaroni, et al., “Hepatocellular Carcinoma: Radiofrequency Ablation of Medium and Large Lesions,” Radiology, Vol. 214, No. 3, 2000, pp. 761-768.
[3]	S. Ross, M. Di Stasi, E. Buscarini, et al., “Percutaneous Ultrasound-Guided Radiofrequency Electrocautery for the Treatment of Small Hepatocellular Carcinoma,” Journal of Interventional Radiology, Vol. 8, 1993, pp. 97-103.
[4]	N. Hotta, T. Maeno, M. Ayada, et al., “Four-Dimensional Ultrasonography for Therapeutic Radiofrequency Ablation for Hepatocellular Carcinoma,” Hepato-Gastroenterology, Vol. 53, No. 70, 2006, pp. 521-525.
[5]	N. Hotta, T. Tagaya, T. Maeno, et al., “Advanced Dynamic Flow Imaging with Contrast-Enhanced Ultrasonography for the Evaluation of Tumor Vascularity in Liver Tumors,” Clinical Imaging, Vol. 29, No. 1, 2005, pp. 34- 41. doi:10.1016/j.clinimag.2004.03.001
[6]	T. Teratani, H. Yoshida, S. Shiina, et al., “Radiofrequency Ablation for Hepatocellular Carcinoma in So-Called High-Risk Locations,” Hepatology, Vol. 43, No. 5, 2006, pp. 1101-1108. doi:10.1002/hep.21164
[7]	K. Katayama, Y. Oosaki, A. Uemura, et al., “Saline Injection into the Pleural Cavity to Detect Tumors of the Hepatic Dome with Sonography: A New Approach for Treatment of Hepatocellular Carcinoma,” American Journal of Roentgenology, Vol. 179, No. 1, 2002, pp. 102-104.
[8]	N. Hotta, M. Ayda, E. Matsumoto, et al., “Usefulness of Radiofrequency Ablation with Micro-Convex Probe for Hepatocellular Carcinoma,” Hepato-Gastroenterology, Vol. 56, No. 93, 2009, pp. 1127-1132.
[9]	Y. Matsuda and I. Yabuuchi, “Hepatic Tumors: US Contrast Enhancement with CO2 Microbubbles,” Radiology, Vol. 161, No. 3, 1986, pp. 701-705.
[10]	S. R. Wilson, P. N. Burns, D. Muradali, et al., “Harmonic hepatic US with Microbubble Contrast Agent: Initial Experience Showing Improved Characterization of Hemangioma, Hepatocellular Carcinoma, and Metastasis,” Radiology, Vol. 215, No. 1, 2000, pp. 153-161.
[11]	K. Numata, K. Tanaka, T. Kiba, et al., “Contrast- Enhanced, Wide-Band Harmonic Gray Scale Imaging of Hepatocellular Carcinoma: Correlation with Helical Computed Tomographic Findings,” Journal of Ultra-sound in Medicine, Vol. 20, No. 2, 2001, pp. 89-98.
[12]	N. Hotta, T. Tagaya, T. Maeno, et al., “Usefulness of Contrast-Enhanced Ultrasonography with Dynamic Flow Imaging to Evaluate Therapeutic Effects for Hepatocellular Carcinoma,” Hepato-Gastroenterology, Vol. 50, No. 54, 2003, pp. 1867-1871.
[13]	S. R. Wilson and P. N. Burns, “An Algorithm for the Diagnosis of Focal Liver Masses Using Microbubble Contrast-Enhanced Pulse-Inversion Sonography,’ American Journal of Roentgenology, Vol. 186, No. 5, 2006, pp. 1401-1412. doi:10.2214/AJR.04.1920